Journal of the National Cancer Institute Advance Access originally published online on December 9, 2008
JNCI Journal of the National Cancer Institute 2008 100(24):1741; doi:10.1093/jnci/djn487
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
MEMO TO THE MEDIA |
Nonhormonal Treatment Regimens Substantially Improve Overall Survival in Patients with Metastatic Breast Cancer
| The first 10% of the full text of this article appears below. |
Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute.
Numerous regimens have been tested in advanced breast cancer. However,
Contact:
Citation:
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 616-617.
J Natl Cancer Inst 2008 100: 1745-1747.